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Abstract: The cellular response to the recombinant NS1 protein of West Nile virus (NS1WNV) was
studied using three different cell types: Vero E6 simian epithelial cells, SH-SY5Y human neuroblastoma
cells, and U-87MG human astrocytoma cells. Cells were exposed to two different forms of NS1WNV:
(i) the exogenous secreted form, sNS1WNV, added to the extracellular milieu; and (ii) the endogenous
NS1WNV, the intracellular form expressed in plasmid-transfected cells. The cell attachment and
uptake of sNS1WNV varied with the cell type and were only detectable in Vero E6 and SH-SY5Y
cells. Addition of sNS1WNV to the cell culture medium resulted in significant remodeling of the
actin filament network in Vero E6 cells. This effect was not observed in SH-SY5Y and U-87MG cells,
implying that the cellular uptake of sNS1WNV and actin network remodeling were dependent on cell
type. In the three cell types, NS1WNV-expressing cells formed filamentous projections reminiscent of
tunneling nanotubes (TNTs). These TNT-like projections were found to contain actin and NS1WNV
proteins. Interestingly, similar actin-rich, TNT-like filaments containing NS1WNV and the viral
envelope glycoprotein EWNV were also observed in WNV-infected Vero E6 cells.
Keywords: flavivirus; West Nile virus; non-structural protein 1 (NS1); cytoskeleton; actin network;
tunneling nanotubes
1. Introduction
Flaviviruses, belonging to the Flaviviridae family, are enveloped, positive-strand RNA viruses
that can be transmitted to humans by mosquito and tick bites. Flaviviruses such as dengue virus,
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Zika virus, West Nile virus (WNV), Japanese encephalitis, and yellow fever virus are human pathogens
that cause diseases varying from asymptomatic infections or febrile illness to encephalitis, meningitis,
or hemorrhagic shock, all of which can have a possible fatal outcome [1]. The genomes of flaviviruses
encode a single viral polyprotein that is processed by viral and host cell proteases to give three
structural proteins, namely, C (core), prM/M (membrane), and E (envelope); and seven non-structural
proteins, namely, NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5 [2].
The non-structural protein NS1 has a molecular weight of 46 to 55 kDa, depending on its
N-glycosylation status. NS1 is synthesized as a monomer, which dimerizes after post-translational
modification in the lumen of the rough endoplasmic reticulum [3], and is secreted into the extracellular
space as a hexameric lipoprotein particle [1,4]. During flavivirus infections, the NS1 protein exists in
multiple oligomeric forms, and is found either intracellularly and extracellularly [5–7]. Three different
forms of NS1 have been described: an intracellular membrane-associated form [8,9], a cell surface-bound
form, and a secreted form (sNS1) [4,10–12]. The intracellular dimeric NS1 colocalizes with dsRNA
and other components of the viral replication complex, and plays an essential cofactor role in virus
replication [1,13]. NS1 is not present in the viral particles, but is found as membrane-associated dimers
and secreted, lipid-associated hexamers [1,4].
In recent years, there has been renewed interest in the role of the NS1 protein in viral pathogenesis.
The NS1 genes of flaviviruses share a high degree of sequence homology, and crystallographic analyses
of NS1 crystals have shown that their three-dimensional (3D) structures are almost identical [10].
Numerous studies have demonstrated the multifunctional nature of NS1. Intravenous administration
of mice with the dengue virus (DENV) NS1 secreted form (sNS1DENV) showed accumulation of
sNS1DENV in the liver and its association with hepatocytes [14]. Further, sNS1DENV can bind directly
to the plasma membrane of uninfected epithelial and fibroblastic cells in vitro via interactions with
glycosaminoglycans (heparan sulfate or chondroitin sulfate E) or Toll-like receptors (TLRs) [10,15–18].
Interestingly, sNS1DENV has differential cell-binding specificity, as it binds efficiently to epithelial and
mesenchymal cells but poorly to peripheral blood cells.
In the extracellular milieu, sNS1 exerts a positive effect on flavivirus infection and pathogenesis
through its interaction with multiple components of the innate and adaptive immune systems, and its
implication in the viral evasion from the host antiviral response [1,10,19–22]. NS1 also inhibits the
host interferon-β production by acting as an antagonist of the RIG-I-like-receptor (RLR)-mediated
pathway [23]. Blood-circulating and cell-surface-associated sNS1 are both highly immunogenic,
and sNS1 protein or anti-NS1 antibodies are early diagnostic biomarkers of flavivirus infection used in
clinical assays [1,9,10,16,24–27].
As with many other viruses, flaviviruses subvert and utilize the cytoskeleton to infect their
host cells [28,29]. This has been well-documented by cytological analyses in the early steps of virus
internalization and intracellular trafficking, and also in the late steps of viral particle assembly and
release [28,30–37]. Direct evidence of NS1–actin interaction was provided by a study showing that
NS1DENV protein was recovered from the cytoskeletal fraction of DENV-infected human endothelial
cells (EA.hy926) at relatively late times (ca. 12 h) post infection [35]. More recently, the β-actin-related
protein T1 was identified in the interactome of NS1DENV with different human cell types, namely,
Raji (lymphoblastoid), HeLa (epithelial), and HAP1 (myeloid) cells [38], and with the actin-related
protein 10 among the interactors of NS1DENV in the human hepatocellular carcinoma cell HepG2 [39].
Tunneling nanotubes (TNTs) are actin-rich projections that facilitate long-distance intercellular
communication [40–43]. They are thin membrane channels that form intercellular bridges and
allow direct, cell-to-cell transfer of organelles and cytoplasmic molecules [44]. The architecture
and ultrastructural organization of neuronal TNTs were recently elucidated by using correlative focus
ion beam-scanning and transmission electron microscopy (EM) in combination with cryo-fluorescence
microscopy, cryo-EM, and cryo-electron tomography [45]. Recent studies have shown that viruses
can take advantage of these channels for their intercellular transmission, with minimal exposure
to the extracellular environment [46]. This has been described for retroviruses [47–52], influenza
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virus [53], vaccinia virus [54,55], pseudorabies virus [56,57], and herpes simplex virus [58], as well
as for neuron-to-neuron transfer of pathological Tau protein assemblies and prion-like proteins in
neurodegenerative diseases [59–61].
In this study, we further investigated the multiple properties of the NS1 protein of the West Nile
virus (NS1WNV). We tested the capacity of the extracellular, secreted form of recombinant NS1WNV
(sNS1WNV) to attach and enter cells, and to possibly affect the cytoskeletal network upon its cellular
uptake. The cellular alterations associated with the expression of recombinant NS1WNV proteins were
also analyzed. Three different cell types were used in our study: simian epithelial cells (Vero E6),
human neuronal cells (SH-SY5Y), and human glial cells (U-87MG). We observed that sNS1WNV
attachment to cells and cellular uptake varied with the cell type and was more efficient in Vero E6
and SH-SY5Y cells than in U-87MG. Modification of the cellular actin filament network was found
to be associated with NS1WNV in different types of experimental setups: (i) Addition of purified
secreted sNS1WNV protein to the cell culture medium (exogenous sNS1WNV) resulted in a significant
but transient remodeling of the actin cytoskeleton in Vero E6 cells. (ii) Upon intracellular expression
of recombinant NS1WNV protein (endogenous NS1WNV), actin-rich, TNT-like projections containing
NS1WNV were observed in the three cell types. (iii) Similar filamentous projections forming intercellular
bridges were observed in WNV-infected Vero E6 cells in the late stages of the virus cycle, and these
actin-rich filaments were found to contain NS1WNV and the viral envelope glycoprotein EWNV.
Interestingly, incubation of cells with sNS1WNV, added before or concomitantly to WNV, did not
significantly change the infectiveness of the virus in any of the studied cell types. Collectively, our results
confirmed the multiplicity of functions associated with the flaviviral NS1 proteins, but the common
molecular mechanism remains to be determined.
2. Materials and Methods
2.1. Cells and Virus
Human epithelial cell HEK-293T (ATCC® CRL-3216™), simian epithelial cell Vero E6 (ATCC®
CRL-1586™), human astrocytoma cell U-87MG (ATCC® HTB-14™), and human neuroblastoma
cell SH-SY5Y (ATCC® CRL-2266™) were provided by CelluloNet (SFR-Biosciences, Lyon, France).
HEK-293T, Vero E6, and U-87MG cells were grown in Dulbecco’s modified Eagle’s medium (DMEM;
GlutaMAX, high glucose, Gibco™, Thermo Fisher Scientific, Carlsbad, CA, USA) supplemented with
10% heat-inactivated fetal bovine serum (FBS; Gibco™). SH-SY5Y cells were grown in DMEM/nutrient
mixture F-12 (DMEM/F-12, Ham 1:1, GlutaMAX, Gibco™) supplemented with 2% heat-inactivated
FBS. Cell cultures were maintained at 37 ◦C and 5% CO2. For the production of recombinant sNS1
protein, geneticin™-G418 (500 µg/mL, Gibco™) was added to the culture medium of HEK-293T cells
3 days before seeding them for transfection.
The IS-98-ST1 strain of WNV (provided by Dr. S. Lecollinet; ANSES-ENVA, Maisons-Alfort,
France) is a highly virulent strain isolated from a stork with severe neurological symptoms during
the 1998 epidemic in Israel [62]. Working stocks of WNV IS-98-ST1 were generated by a single round
of amplification in Vero E6 cells. Titers of virus stocks were determined by a standard serial dilution
plaque assay in Vero E6 cells, and results expressed as PFU/mL [1,63].
2.2. Cloning of NS1
The NS1-coding gene from the WNV strain IS-98-ST1 was cloned in fusion with the coding
sequence of a flexible linker (Gly-Ser-Gly) and an oligo-histidine tag (6× His) at the carboxy terminus.
A similar tag has been previously added to the NS1DENV protein, without any detrimental effect on
its structural and biological properties [10,64]. The coding sequence of the C-terminal region of the
E gene (72 nucleotides) was conserved at the 5’ end of the construct, as it contains the ER-targeting
sequence and the host protease cleavage site. Bam HI and Xho I restriction sites were added at the 5’
and 3’ ends, respectively, using polymerase chain reaction (PCR) with the following primers: forward
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5’-GGATCCAATACGGAATTCATGCAGCTGTTGAATTTTGACCTTCTCAAGCTTGCG-3’, and reverse
5’- CTCGAGTCACTAGTGGTGATGGTGATGATGGCCGCTTCCAGCATTCACTTGTGACTACG-3’.
The fragment thus obtained was digested by Bam HI and Xho I (New England BioLabs, NEB™, Ipswich,
MA, USA) and inserted into the Bam HI/Xho I-linearized pcDNA3.1 expression vector, using T4
DNA Ligase (NEB™), according to the manufacturer’s instructions. The chemically competent E. coli
bacterial strain Top10 was used for plasmid construct propagation. Standard procedures were followed,
except for the temperature of transformed bacterial cells propagation (28 ◦C). The quality of the plasmid
construct, abbreviated as pNS1WNV-IS98 in the present study (Supplementary Figure S1), was verified
by DNA sequencing. The empty pcDNA3.1 plasmid vector was used as negative control.
2.3. NS1 Production and Purification
One day before transfection, 4 × 106 HEK-293T cells were seeded in 100 mm diameter Petri dishes
in serum-reduced culture medium (DMEM, 1% FBS). On the following day, cells were transfected
with 10 µg plasmid pNS1WNV-IS98, using Lipofectamine® 2000 Transfection Reagent (Invitrogen™,
Thermo Fisher Scientific, Carlsbad, CA, USA), following the manufacturer’s recommendations.
Another batch of cells was transfected with empty pcDNA3.1 vector as negative control. At 6 h
post-transfection, the medium was replaced by fresh DMEM supplemented with 1% FBS, and cells
were further incubated at 37 ◦C, 5% CO2 for 3 days. The culture medium was then collected, filtered
through 0.2 µm pores, and stored at 4 ◦C before NS1 purification. Fresh culture medium was added to
the cells for a further 2-day period, then culture medium was again collected, filtered, and pooled with
the previous batch stored at 4 ◦C.
His-tagged native protein sNS1 was purified by affinity chromatography on a nickel resin column.
The pooled sNS1-containing culture medium was mixed with an equal volume of equilibration
buffer (300 mM NaCl, 10 mM Imidazole, pH 7.4 in PBS). The sNS1-containing mix was then loaded
onto a column of Ni-NTA resin (HisPur Ni-NTA resin, Thermo Fisher Scientific™) equilibrated with
equilibration buffer. Resin was rinsed with wash buffer (PBS, 25 mM Imidazole, pH 7.4). Elution of the
sNS1 protein was carried out with PBS containing 250 mM imidazole, pH 7.4. Eluate was dialyzed
overnight against PBS at 4 ◦C, using SnakeSkin dialysis tubing (7 kDa MWCO, 22 mm; Thermo
Fisher Scientific™). In parallel, the same putification protocol was applied to negative control samples
(CtrlpcDNA3.1), corresponding to the culture medium of empty pcDNA3.1-transfected HEK-293T cells.
The sNS1 concentration was determined in the dialyzed samples, using Bradford protein microassay
(protein assay dye reagent, Cat. #5000006, Bio-Rad™, Hercules, CA, USA). Absorbance was measured
using the Victor® microplate reader (Perkin Elmer, Waltham, MA, USA). All the samples were stored
at −80 ◦C until further use.
2.4. Antibodies
Mouse monoclonal anti-5× His tag antibody was purchased from Qiagen (penta-His antibody,
Cat. #34660). The mouse monoclonal anti-flavivirus NS1 antibody (Cat. #Ab214337) and the
rabbit polyclonal anti-α-tubulin antibody (Cat. #Ab15246) were from Abcam. The fluorescent
secondary antibodies Alexa Fluor®488-labeled goat anti-mouse IgG antibody (Cat. #A11029), Alexa
Fluor®633-labeled goat anti-rabbit IgG antibody (Cat. #A21070), and Alexa Fluor®546-labeled goat
anti-rabbit IgG antibody (Cat. #A11035) were from Invitrogen. The rabbit polyclonal antibody against
domain III of EWNV (anti-WNV-EDIII) was kindly provided by Dr. S. Lecollinet (ANSES-ENVA,
Maisons-Alfort, France).
2.5. Protein Gel Electrophoresis and Western Blotting
Total cellular proteins were extracted using RIPA lysis buffer (100 µM NaCl, 20 mM Tris-HCl
pH 7.4, 1 mM ethylenediaminetetraacetato (EDTA), 0.5% sodium deoxycholate, 1% sodium dodecyl
sulfate (SDS)) containing a protease inhibitor cocktail (Halt™ protease inhibitor cocktail, Thermo Fisher
Scientific™). Samples were denatured by heating at 95 ◦C for 5 min in an equal volume of two-fold
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concentrated loading buffer (2× loading buffer: 1 M Tris-HCl pH 6.8, containing 0.5 M Na2EDTA,
10% (w/v) SDS, 14.3 M β-mercaptoethanol, 20% (v/v) glycerol, and 0.04% (w/v) bromophenol blue).
In parallel, heat treatment was omitted in corresponding samples, and proteins were denatured by
mild treatment in SDS/β-mercaptoethanol loading buffer only, at room temperature (RT) for 10 min.
Proteins were electrophoresed in SDS-containing 10% polyacrylamide gel (SDS-PAGE), and electrically
transferred to nitrocellulose membranes (TransBlot® system, Bio-Rad™). Blots were blocked for 1 h at
RT in Tris-buffered saline (TBS) containing 0.05% Tween-20 (TBS-T) supplemented with 5% non-fat
dry milk (blotto milk). Membranes were then incubated overnight at 4 ◦C with mouse monoclonal
anti-flavivirus NS1 antibody (1:1000) or anti-5× His tag antibody (1:2000) in TBS-T supplemented with
1% blotto milk. After extensive washes with TBS-T, membranes were incubated with HRP-conjugated
goat anti-mouse IgG (1:10,000 dilution, Sigma-Aldrich) for 1 h at RT. NS1 protein was detected using
a chemiluminescent substrate (SuperSignal® West Pico, Thermo Fisher Scientific™), and visualized
using a ChemiDoc® XRS+ system with Image Lab™ software (Bio-Rad™).
2.6. Confocal Fluorescence Microscopy
To study the expression and localization of NS1WNV protein in plasmid-transfected or
WNV-infected cells, or to monitor the NS1WNV protein in sNS1WNV-treated cells, cells were fixed in
PBS containing 4% paraformaldehyde for 30 min, then permeabilized with 0.5% Triton X-100 in PBS.
Nonspecific signals were blocked with PBS containing 0.1% Triton X-100, 5% FBS (PBS–T-FBS). NS1 was
detected using mouse monoclonal anti-flavivirus NS1 antibody (1:250 in PBS–T-FBS), followed by Alexa
Fluor®488-labeled goat anti-mouse IgG antibody (1:500 in PBS–T-FBS). Expression and localization
of viral E protein in infected cells (MOI 0.5) were monitored by reaction with rabbit polyclonal
anti-WNV-EDIII antibody (1:500 in PBS–T-FBS), followed by Alexa Fluor®633-labeled goat anti-rabbit
IgG antibody (1:500 in PBS–T-FBS). In transfected cells, α-tubulin was detected with rabbit polyclonal
anti-α-tubulin antibody (1:250 in PBS–T-FBS), followed by Alexa Fluor®633-labeled goat anti-rabbit IgG
antibody (1:500 in PBS–T-FBS). In WNV-infected cells, labeling of α-tubulin was performed using Alexa
Fluor®546-labeled goat anti-rabbit IgG antibody (1:500 in PBS–T-FBS). Actin microfilament (F-actin)
staining was performed by reaction with rhodamine–phalloidin conjugate (R415, Invitrogen, Thermo
Fisher Scientific™; 1:500 in PBS–T-FBS). Nuclei were stained with 4’,6-Diamidino-2-Phenylindole,
dihydrochloride (DAPI) in PBS–T-FBS (1 µg/mL). Samples were examined under a Leica™ TCS SP5
laser scanning confocal microscope. All confocal images were acquired with strictly the same settings
and analyzed using the LCS AF software. The Z-resolution was 400–600 nm, a value compatible with
a nanofilament of 50–200 nm in diameter.
For kinetic analysis of actin network modifications occurring in sNS1WNV-treated cells, cell samples
were collected at different times of incubation with sNS1WNV at 37 ◦C (up to 24 h), fixed, and then stained
with rhodamine–phalloidin. Negative controls consisted of mock-treated cells (i.e., cells incubated
with samples from the culture medium of HEK-293T cells transfected with empty plasmid pcDNA3.1,
subjected to the same chromatographic process as the culture supernatant of pNS1WNV-IS98-transfected
cells). A total of 140 to 330 individual cells were examined by fluorescence microcopy in at least 5 to
10 separate microscopic fields. Images were acquired with the Leica™ TCS SP5 laser scanning confocal
microscope, and cells with absent or disorganized actin microfilament networks were counted using
the ImageJ program. The results were expressed as the percentage of total cells examined per field.
Statistical analyses were performed using the Mann–Whitney test.
2.7. Flow Cytometry Analysis of Cell Attachment and Uptake of NS1WNV
Cells were seeded with complete media in 24- or 48-well plates to obtain a confluency of 70%–80%
the following day. Cells (5 × 105) were incubated with recombinant sNS1WNV (10 µg/mL) or control
sample (purified supernatant from pcDNA3.1-transfected HEK-293T cells) in PBS containing 10% FBS
for 1 h on ice, and rinsed three times with ice-cold PBS. They were detached with PBS containing 0.01%
trypsin and 1 mM Na2EDTA, then fixed with 4% paraformaldehyde in PBS for 30 min. To determine
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the level of cell surface-attached sNS1WNV, cells were incubated with mouse anti-NS1 antibody
(1:250 in PBS) for 1 h on ice.
To analyze the cell internalization of sNS1WNV, cells were first incubated with sNS1WNV for 1 h
on ice to allow cell attachment, rinsed with ice-cold PBS, then transferred to 37 ◦C for 6 h to allow
cellular internalization of sNS1WNV. Cells were detached with PBS containing 0.01% trypsin and
1 mM Na2EDTA, fixed in PBS containing 4% paraformaldehyde for 30 min, and permeabilized with
PBS containing 0.1% saponin and 10% FBS for 15 min on ice. NS1 was reacted with mouse anti-NS1
antibody (1:250 in PBS) for 1 h on ice, as above. In both cases, the detection of sNS1WNV-positive cells
was performed using a 1:500 dilution of AlexaFluor 488-conjugated goat anti-mouse IgG antibody
for 1 h on ice. Cells were then rinsed 3 times with ice-cold PBS, resuspended in PBS containing 1%
paraformaldehyde, and analyzed in a BD FACSCalibur™ flow cytometer.
2.8. Transmission Electron Microscopy
Samples of purified sNS1 were applied to a carbon film using the standard mica-carbon flotation
technique, and negatively stained with 1% (w/v) uranyl acetate. They were examined under a JEOL
(JEM-1200EXII) electron microscope at 100 kV. Images were acquired and analyzed by digital micrograph
software (Gatan Inc., Pleasanton, CA, USA).
2.9. Transfections
On the day prior to transfection, 5 × 104 Vero E6 cells or 8 × 104 U-87MG and SH-SY5Y cells were
seeded in 8-well plates (Nunc© Lab-Tek, Thermo Fisher Scientific, Carlsbad, CA, USA), and maintained
in their respective media. On the next day, cells were transfected with 500 ng of pNS1WNV-IS98
plasmid or control empty pcDNA3.1, using Lipofectamine® 2000 Transfection Reagent (Invitrogen™,
Thermo Fisher Scientific), according to the manufacturer’s recommendations. At 6 h post-transfection,
medium was replaced by fresh complete medium. Cells were fixed with 4% paraformaldehyde and
processed for immunostaining.
2.10. Kinetics of WNV Replication and Virus Titration
WNV titration was performed as previously described [63]. In brief, VeroE6 cells were seeded at
1 × 105 cells per well, and SH-SY5Y and U-87MG cells were seeded at 2 × 105 cells per well of 48-well
plates, in DMEM supplemented with 10% FBS (Gibco). The next day, the cells were incubated with
sNS1WNV (10 µg/mL) or with an aliquot of control sample from empty plasmid pcDNA3.1-transfected
cells for 5 h at 37 ◦C with 5% CO2, before or concomitantly to virus addition. WNV-IS98 inoculum at
different MOI (in DMEM supplemented with 2% FBS for Vero E6 and U-87MG, and in DMEM/F12
supplemented with 2% FBS for SH-SY5Y) was added to the wells and incubated for 2 h at 37 ◦C and
5% CO2. Cells were rinsed twice with fresh DMEM, then further incubated at 37 ◦C and 5% CO2
in DMEM supplemented with 10% FBS for Vero E6 and U-87MG, and in DMEM/F12 supplemented
with 2% FBS for SH-SY5Y. Cell supernatants were collected at different times post-infection, and virus
progeny titers (expressed as Log10TCID50/mL) were determined by end point dilution assays in Vero
E6 cells, using the Reed and Muench method [1,63].
3. Results
3.1. Expression and Characterization of Intracellular and Secreted Form of NS1WNV in Mammalian Cells
Recombinant His-tagged NS1 protein was produced in pNS1WNV-IS98-transfected HEK-293T cells
and isolated from the cell culture medium as the secreted form of NS1 protein (abbreviated sNS1WNV).
HEK-293T cell lysates and culture supernatants were analyzed by SDS-PAGE and Western blotting,
using the standard procedure of protein denaturation by SDS treatment at 95 ◦C, or, alternatively,
heat-denaturation was omitted to preserve the oligomeric structures. In the latter case, samples were
only treated with SDS at room temperature, with no chemical cross-linker.
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The majority of the intracellular NS1WNV protein occurred as dimers of 110 kDa at 24 h
post-transfection (pt; Figure 1a). The secreted sNS1WNV protein (55 kDa) was detected in low amounts
in the culture supernatant as early as 24 h pt, and the maximum extracellular release was observed
at 72 h pt (Figure 1b). No apparent cytotoxicity was observed for the sNS1WNV-producer cells up
to 72 h pt, as shown by MTT assays. After affinity purification, the majority of sNS1WNV protein in
non-heated, SDS-treated samples migrated as dimers, but monomers were also present in significant
amounts (Figure 1c).
After purification by affinity chromatography, the final recovery of sNS1WNV was about 2 µg
protein per 106 cells over a 5 day culture period (2.15 ± 0.45 pg/cell; mean ± SD, n = 4). In the absence
of an available antibody specific to sNS1WNV hexamers, their proportion was impossible to assess.
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Figure 1. Expression and secretion of the recombinant NS1WNV protein into the culture medium
of pNS1WNV-IS98-transfected HEK-293T cells. (a) Ki etics of intracellular expression of NS1WNV.
Whole cell lysates (WCL) were denatured in SDS/β-mercaptoethanol-containing loading buffer at r om
temperature (RT) to preserve the oligomeric status of protei s (leftmost lanes), or su jected to the
usual heat denaturation at 95 ◦C for 5 min in loading buffer (rightmost lanes). Proteins were analyzed
by SDS-PAGE and Western blotting. H6-tagged NS1WNV protein was detected using anti-His6 tag
antibody. Note: * = the protein band migrating with an apparent mwt of 58 kDa and visible in both
control and S1-expressing samples might correspond to the superimposition of an anti-His6-tag
antibody-reacting cellular protein and a post-translationally modified form of the NS1WNV protein.
(b) Secretion of sNS1WNV protein. Samples from the culture medium of pNS1WNV-98-transfected cells were
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collected at the indicated times post-transfection (pt), heat-denatured in SDS/β-mercaptoethanol-
containing loading buffer, and analyzed by SDS-PAGE and Western blotting. (c) Purification and
oligomeric status of sNS1WNV. Extracellular H6-tagged sNS1WNV, isolated by affinity chromatography
on Ni2+-agarose column, was analyzed by SDS-PAGE and Western blotting after mild denaturation in
SDS/β-mercaptoethanol-containing loading buffer at RT. Abbreviations: D = sNS1WNV dimers; M =
sNS1WNV monomers; Ctrl = negative control samples; mwt = molecular weight (kDa).
Electron microscopic (EM) observation of negatively stained sNS1 samples purified by affinity
chromatography showed that the secreted recombinant sNS1WNV protein presented the same structural
characteristics as those previously reported for other flaviviral NS1 proteins [10,65]. The top view and
side view EM images of our sNS1WNV protein (Figure 2) were consistent with a hexameric structure,
as previously shown for the sNS1 protein of dengue virus (NS1DENV) using 3D reconstruction [4].
The fact that dimers—but no hexamers—were detected by SDS-PAGE analysis of non-heated,
SDS-treated samples of sNS1WNV (Figure 1c), even in gels of low acrylamide concentration, implied that
sNS1WNV dimers interacted via noncovalent links more resistant to SDS dissociation, compared to the
other links involved in the whole hexameric structure.
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Figure 2. Electron microscopy control of extracellular sNS1WNV. Samples from the extracellular
medium of pNS1WNV-IS98-transfected HEK-293T cells were purified by affinity chromatography on
a Ni2+-agarose column, and the oligomeric status of sNS1WNV proteins was verified by electro
microscopy (EM). (a) EM images of negatively stained samples observed at low (i) and high (ii)
magnifications. (iii,iv) Enlargements of individual sNS1WNV hexamers. (b) Three-dimensional model
previously proposed for NS1DENV [4], and comparison with enlargements of sNS1WNV hexa ers
presented from different incidences—top and side views.
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This was in agreement with a previous study showing that the hexamers of NS1DENV are unstable
in non-ionic detergents, whereas the interfaces between the dimeric subunits are very narrow and
contribute to the stabilization of the dimers [4]. Our result confirmed that NS1 dimers constitute
the building blocks of the NS1 hexameric scaffold, and that three dimers are held together by weak
hydrophobic interaction to form one hexamer [4].
3.2. Cell Attachment and Uptake of sNS1WNV
It has been reported that sNS1DENV can bind to the cell membrane of epithelial and fibroblast
cells [15], and that NS1WNV binds to HEK-293T cells, followed by its internalization within 6 h [16].
Therefore, we compared the cell attachment and cellular uptake of sNS1WNV in three different cell
types: (i) Vero E6, a simian kidney epithelial cell line; (ii) SH-SY5Y, a human neuroblastoma cell line;
and (iii) U-87MG, a human astrocytoma cell line. All three cell lines are permissive to WNV infection.
The cells were incubated with sNS1WNV at 10 µg/mL for 1 h and 6 h, respectively, and analyzed by flow
cytometry for cell-bound sNS1WNV (1 h samples, maintained at low temperature) and intracellular
NS1WNV (6 h samples, subjected to temperature increase and cell permeabilization). After a 1 h
incubation period, sNS1WNV proteins were detectable on the surface of non-permeabilized Vero E6 and
SH-SY5Y cells, and in significantly lower amounts on the surface of U-87MG cells (Figure 3). After 6 h
incubation, sNS1WNV was efficiently internalized into Vero E6 and SH-SY5Y cells, but not in U87MG
cells (Figure 3). These results implied that even though sNS1WNV could bind to a variety of cells,
as previously reported [10,14,15,18], the cellular uptake of sNS1WNV was cell-type-dependent.
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Figure 3. Cell attachment and uptake of recombinant sNS1WNV by different cell types. Aliquots
of extracellular, H6-tagged sNS1WNV pr tein, released by pNS1WNV-IS98-t a sfected HEK-293T cells
and purified by affinity chromatography, w r ad ed to the cell culture m dia of Vero E6, SH-SY5Y,
and U-87MG cells, at a final concentration of 10 µg/mL. In one series of samples, cells were collected after
1 h incubation on ice (gray bars) and cell-bound NS1WNV was detected nd quantified by flow cy ometry.
In another series (bla k ba s), cells were first incubated on ice for 1 h, then transferred to 37 ◦C for 6 h,
permeabilized, and intrac llular NS1WNV was evaluated by flow cytometry. Control mock-t eated
cells were incubated with samples from th c lture medium of HEK-293T cells transfected with empty
plasmid pcDNA3.1, subjected to the same chromatographic process as the culture supernatant of
pNS1WNV-IS98-transfected cells. The mean fluorescence intensity (MFI) values shown in the bar graph
(expressed in arbitrary units; AU), represented the mean values (m ± SD) of duplicate samples from two
separate experiments, corrected by subtraction of the values of the signal obtained with mock-treated
cells. Statistical analyses ere performed using the Mann–Whitney test. Note: ** = P ≤ 0.01.
3.3. Cytoskeletal Modifications Associated with sNS1WNV Internalization
We then analyzed the effect of the internalization of sNS1WNV on the cytoskeleton of Vero E6,
SH-SY5Y, and U-87MG cells. Recombinan sNS1W was added to the culture medium at 10 µg/mL,
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and the cells were harvested and fixed after 2 h, 6 h, 8 h, and 24 h. The presence of intracellular
NS1WNV and the morphological status of the actin and tubulin networks were analyzed by confocal
fluorescence microscopy. The NS1WNV signal was detected in sNS1WNV-treated Vero E6 cells as early
as 2 h post-incubation, reaching a maximum at 6 h (Figure 4A). NS1WNV was still visible at 8 h, but no
longer detectable at 24 h (Figure 4A).
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Figure 4. Time-course analysis of the cellular uptake of sNS1WNV by Vero E6 cells. Extracellular,
soluble H6-tagged sNS1WNV protein, released by pNS1WNV-IS98-transfected HEK-293T cells and purified
by affinity chromatography, was added to the cell culture medium of Vero E6 cells at 10 µg/mL. Control,
mock-treated cells consisted of cells incubated with aliquots from the culture medium of HEK-293T cells
transfected with empty plasmid pcDNA3.1, and were subjected to the same chromatographic process
as the culture supernatant of pNS1WNV-IS98-transfected cells. Cells were fixed at different periods of
incubation at 37 ◦C in the presence of sNS1WNV (0 to 24 h, as indicated on the left side of panels (A,B),
and analyzed by confocal fluorescence microscopy. (A) Control Vero E6 cells. (B) Vero E6 cells incubated
with sNS1WNV. (C) Enlargements of microscopic images of sNS1WNV-treated cells (6 h incubation time,
delineated by a white square). Actin microfilaments (red) were visualized using rhodamine–phalloidin,
nuclei (blue) were visualized using dihydrochloride (DAPI) reagent, and sNS1WNV protein (green) was
immunolabeled using anti-NS1WNV rabbit antibody. Note that images in panels (A–C) show the same
areas at a given time point.
In parallel, a significant remodeling of the cellular actin network was observed between 6 h
and 8 h (Figure 4B). These alterations were transient and followed the evolution of the NS1WNV
content; after a maximum disorganization at 6–8 h, the actin network was completely restored at 24 h
(Figures 4B and 5). This suggested that the extent of actin depolymerization correlated with the level of
intracellular NS1WNV. A direct negative effect of NS1WNV on actin biosynthesis was unlikely, as shown
by the absence of significant change in actin levels over time in NS1WNV-expressing HEK-293T cells
(refer to Figure 1a).
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Figure 5. Kinetics of actin remodeling in sNS1WNV-treated Vero E6 cells. Extracellular, soluble
H6-tagged sNS1WNV protein, released by pNS1WNV-IS98-transfected HEK-293T cells and purified by
affinity chromatography, was added to the cell culture medium of Vero E6 cells, at a final concentration of
10µg/mL. Control, mock-treated cells consisted of cells incubated with samples from the culture medium
of HEK-293T cells transfected with empty plasmid pcDNA3.1, subjected to the same chromatographic
process as the culture supernatant of pNS1WNV-IS98-transfected cells. At different times of incubation
with sNS1WNV at 37 ◦C (0 to 24 h), cells were fixed and stained with rhodamine–phalloidin. (A) Schematic
representation of cells grouped according to different F-actin morphologies. (I) Cells with organized
actin fibers, as observed in the majority of mock-treated cells. (II) Cells showing reduced number
of organized actin filaments, and notably the absence of perinuclear actin network. (III) Cells
showing total absence of actin filaments. (B) Cell counts. Cells with alterations of the actin network as
defined above were counted using the ImageJ program, and the results of groups (II) and (III) were
pooled and expressed as the percentage of the total number of cells examined per field. A total of
140–330 individual cells were examined by fluorescence microcopy in at least 5–10 separate microscopic
fields. Data presented in the bar graph are mean values (m ± SD) obtained from three separate
experiments. Statistical analyses were performed using the Mann–Whitney test, with p ≤ 0.05 (*);
p ≤ 0.01 (**).
Our observations, therefore, implied that the viral protein sNS1WNV alone had a transient negative
effect on the actin network of epithelial cells. The effect on actin was apparently specific to epithelial cells,
as no remodeling of the actin filament network was visible in sNS1WNV-treated neuronal cell SH-SY5Y
or glial cell U-87MG (not shown). No detectable alteration of the tubulin network was observed in any
of the sNS1WNV-treated cell types, namely, Vero E6, SH-SY5Y, or U-87MG (Supplementary Figure S2).
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3.4. Presence of NS1WNV Protein in Actin-Containing, TNT-Like Nanofilaments Protruding from
NS1WNV-Expressing and WNV-Infected Cells
Since the cell attachment and cellular uptake of sNS1WNV differed for the three cell types,
the possible effects of endogenous NS1WNV on the cytoskeletal network of Vero E6, SH-SY5Y,
and U-87MG cells were analyzed after transfection with pNS1WNV-IS98 plasmid. The actin network
disorganization was less obvious in NS1WNV-expressing Vero E6 cells compared to cells treated with
exogenous sNS1WNV (Figure 6; compare to Figure 4). Only Vero E6 cells overexpressing NS1WNV
protein showed less distinct stress fibers compared to mock-transfected cells (Figure 6a–d).
Interestingly, NS1WNV-expressing Vero E6 cells produced thin and long projections joining one
cell to another and containing both actin and NS1WNV proteins (Figure 6b,f–h). These filamentous
projections resembled the thin, actin-rich membrane channels referred to as tunneling nanotubes
(TNTs), involved in intercellular communication and exchange [40,41,43,44]. In U-87MG cells, TNT-like
filaments were observed in control, mock-transfected cells (Figure 7a), but they seemed to occur with
a higher frequency in NS1WNV-expressing cells (Figure 7b). NS1WNV-expressing SH-SY5Y cells also
showed filamentous protrusions containing actin and NS1WNV, but these structures appeared to be
thicker and shorter compared to the TNT-like nanofilaments observed in Vero E6 or U-87MG cells
(Supplementary Figure S3).
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Figure 6. Actin network in recombinant NS1WNV-expressing Vero E6 cells. Vero E6 cells were transfected
with control empty plasmid pcDNA3.1 (a,e), or with pNS1WNV-IS98 (b–d,f–h). Cells were analyzed
at 24 h pt by confocal fluorescence microscopy, using rhodamine–phalloidin for the visualization
of actin filaments and specific rabbit antibody for the immunolabeling of NS1WNV. (a,b,e,f) Actin
signal; (c,g) NS1WNV signal; (d,h) merged signals. Nuclei were stained in blue using DAPI reagent.
(a–d) Low magnification; (e–h) high magnification. Arrows point to actin- and NS1-containing cellular
TNT-like projections.
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fixed at 18 h post-infection for analysis by confocal fluorescence microscopy. Actin-containing 
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interestingly, they contained both the viral envelope glycoprotein EWNV (Figure 8a) and the non-
structural protein NS1WNV (Figure 8b). In some cases, we observed that TNT-like structures made 
connections to both WNV-infected and non-infected cells, and certain images suggested a possible 
transfer of NS1WNV to non-infected cells (Figure 8c,d). These observations were consistent with the 
results of an earlier study on WNV-infected Vero cells examined at the late stages of infection, 
showing the proliferation of filopodia associated with actin filament thickening, and the presence of 
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Figure 7. Actin network in recombinant NS1WNV-expressing human glial cells U-87MG. U-MG87 cells
were transfected with control empty plasmid pcDNA3.1 (a) or with pNS1WNV-IS98 (b–j) and analyzed
at 24 h pt by confocal fluorescence microscopy, using rhodamine–phalloidin for the visualization
of actin filaments, and specific rabbit antibody for the immunolabeling of NS1WNV. (b,e,h) Actin
signal; (c,f,i) NS1WNV signal; (d,g,j) merged signals. Nuclei were stained in blue using DAPI reagent.
The panels presented in this figure show microscopic fields observed at different magnifications. Note
the coexistence of actin and NS1WNV signals in the cellular projections.
We next determined whether the TNT-like nanofilaments also occurred during WNV infection.
Vero E6 cells were infected with WNV at relatively low multiplicity (MOI 0.5), and the cells were
fixed at 18 h post-infection for analysis by confocal fluorescence microscopy. Actin-containing
filamentous projections emanating from WNV-infected cells were visible (Figure 8), and, interestingly,
they contained both the viral envelope glycoprotein EWNV (Figure 8a) and the non-structural protein
NS1WNV (Figure 8b). In some cases, we observed that TNT-like structures made connections to both
WNV-infected and non-infected cells, and certain images suggested a possible transfer of NS1WNV
to non-infected cells (Figure 8c,d). These observations were consistent with the results of an earlier
study on WNV-infected Vero cells examined at the late stages of infection, showing the proliferation of
filopodia associated with actin filament thickening, and the presence of mature WNV virions in some
of these filopodia [66].
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3.5. NS1WNV and Virus Infectiveness
Considering that NS1WNV was secreted in the extracellular milieu of WNV-infected cells and was
also susceptible to spread from cell to cell via actin-containing cellular nanofilaments, we analyzed the
possible impact of NS1WNV on the WNV life cycle. Vero E6, SH-SY5Y, and U-87MG cells were incubated
with sNS1WNV added to the culture medium 5 h prior to, or concomitantly with, the virus inoculum,
used at MOI 0.01, 0.1, and 1, respectively. WNV-infected cells were then monitored for late cytopathic
effects, and virus replication and progeny yields were determined by end point dilution assays in Vero
E6 cells [1,63]. Interestingly, sNS1WNV did not significantly affect any of these parameters in all three
cell types (Supplementary Figures S4 and S5). This result was somehow expected for U-87MG cells,
considering that these cells did not internalize sNS1WNV in detectable amounts, but not for Vero E6 and
SH-SY5Y cells, which showed an efficient sNS1WNV uptake (refer to Figure 3). Although these negative
data were obtained from in vitro experiments, they might have important implications regarding the
role of NS1 in WNV pathogenicity.
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4. Discussion
The NS1 protein used in this study was derived from WNV-IS-98-ST1, a neurovirulent strain
of lineage 1 that has been well-characterized and is highly pathogenic in animal models [62,67].
Two forms of recombinant NS1WNV protein were tested on cells: the exogenous, secreted form
(sNS1WNV) added to the cell culture medium; and endogenous NS1WNV, the recombinant protein
expressed in pNS1WNV-IS98-transfected cells. The possible cytological effects of NS1WNV were analyzed
using three different types of cells: Vero E6, SH-SY5Y, and U-87MG. The rationale for this choice
was the following: (i) simian kidney epithelial cells Vero E6 are the most widely used host cell line
for WNV propagation and titration; (ii) similar to Vero E6 cells, SH-SY5Y cells are permissive to
WNV infection [68]; (iii) human neuroblastoma cells SH-SY5Y and human astrocytoma cells U-87MG
represented valuable cellular models to study the sNS1WNV-mediated neurovirulence.
Cell attachment and uptake have been well-documented for sNS1DENV compared to the other
flaviviral NS1 proteins. It is generally accepted that sNS1DENV binds to the cell plasma membrane
via interactions with heparan sulfate or chondroitin sulfate E, and that TLRs can serve as alternative
receptors [10,15–18]. After cell attachment, sNS1DENV follows the endocytic pathway and accumulates
in the late endosomal compartment [14]. For the NS1WNV protein, we observed that the exogenous
sNS1WNV was efficiently internalized into Vero E6 and SH-SY5Y cells, reaching a maximum at 6 h
incubation at 37 ◦C; it was not efficiently internalized into U-87MG. The cellular uptake of sNS1WNV,
therefore, varied with the cell type.
The addition of sNS1WNV to the cell culture medium was associated with a significant remodeling
of the actin filament network, and the pattern suggested the depolymerization of the F-actin.
This phenomenon was transient as the actin network progressively reformed in parallel with the
decrease of the intracellular NS1WNV signal. The alteration of the actin network was only observed
in Vero E6 cells and not in the other two cell lines, implying that there was no direct correlation
between the cell internalization of sNS1WNV and alteration of the actin network. The absence of
actin effect in sNS1WNV-treated SH-SY5Y cells, although sNS1WNV was internalized with the same
efficiency as in Vero E6 cells (refer to Figure 3), suggested that the sNS1WNV-associated actin remodeling
was cell-type-dependent.
The cell type specificity of actin remodeling could be related to variable expression of surface
molecules on the different cell types. Thus, tissue-specific variations in the cell binding of flaviviral
NS1 proteins, as well as in the profile of response to inflammatory cytokines in the context of flaviviral
infection, have been reported [69,70]. In terms of intracellular mechanism, a significant activation of
RhoA by phosphorylation has been found in both DENV-infected and NS1DENV-treated human dermal
microvascular endothelial cells, suggesting that the increased endothelial permeability observed during
DENV infection or NS1DENV treatment would be due, at least in part, to RhoA phosphorylation [71].
A quantitative proteomic analysis of brain tissue in WNV-infected mice has shown that several proteins
related to the actin cytoskeleton and Rho GTPase signaling pathway were significantly modified during
the course of neuroinvasive WNV infection [72]. The role of molecules of the Rho GTPase signaling
pathway in cytoskeleton rearrangement, and the consequences on entry, replication, and release of
many viruses, including WNV, have been well-documented [28,29]. It is, therefore, plausible (i) that
the binding of sNS1WNV to a G-protein-coupled receptor present on the surface of certain cells could
activate the cascade of the Rho GTPase signaling pathway; or alternatively (ii) that the intracellular
localization of cell-internalized sNS1WNV would vary with the cell type, and, in some particular cases,
would allow a direct interaction of sNS1WNV with molecules of the Rho GTPase pathway. In both
scenarios, the regulation of actin polymerization would be significantly affected.
The influence of NS1WNV on the cytoskeletal network was then analyzed using endogenous
NS1WNV. The pattern shown by NS1WNV-expressing Vero E6 cells significantly differed from that
observed in cells treated with exogenous sNS1WNV, and only discrete changes in the actin network
were observed (compare Figures 4 and 6). This result supported the first hypothesis formulated above,
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and suggested that the NS1WNV-mediated modulation of the actin network in epithelial cells would
require the attachment of sNS1WNV to the cell surface and its transit via the endocytic pathway.
Examination of NS1WNV-expressing Vero E6 and U-87MG cells showed long and thin projections,
forming intercellular bridges harboring both actin and NS1WNV proteins. These nanofilaments
presented morphological similarities with TNTs, the actin-rich tunneling nanotubes that form
intercellular channels [40,41,43,44]. In contrast, NS1WNV-expressing SH-SY5Y cells showed thicker and
shorter protrusions, but these filamentous structures also contained actin and NS1WNV. The structural
characteristics of the SH-SY5Y protrusions were consistent with the recently elucidated structure of
neuronal TNTs, which are composed of bundles of individual TNTs held together by N-cadherin
fibers [45]. TNTs have been observed in higher numbers in WNV-infected Vero E6 cells compared to
mock-infected cells [66]. Although our study lacked quantitative data, the TNT-like nanofilaments
seemed to occur with a higher frequency in NS1WNV-expressing cells compared to control cells.
Specifically designed methodologies would be necessary to quantify these NS1WNV-containing,
TNT-like structures and determine a possible correlation between their density per cell and the level of
NS1WNV expression.
The TNTs that reached out to connect to neighboring cells, as observed in NS1WNV-expressing and
WNV-infected cells, represented a well-designed launching site for the cell-to-cell transfer of NS1WNV.
It was, therefore, tempting to hypothesize that the extracellular form of NS1WNV (capable of cell
entry), the intra-TNT form of NS1WNV (potentially apt to cell-to-cell trafficking), or both, could prime
uninfected cells present in this region, and increase their permissiveness to newly released WNV virions,
as described for HIV-1 and Nef-induced filopodia [73,74]. We tested this hypothesis and found that
exogenous sNS1WNV (added to the culture medium of WNV-infected cells prior to, or simultaneously
with, the virus) did not significantly change the late cytopathic effects, the replication kinetics, or the
virus progeny yields in any of the three cell types. The absence of a direct effect of exogenous
sNS1WNV on the WNV infectiveness in vitro seemed to exclude its role as a virus facilitating factor
or enhancer. However, the eventuality of such a role is still conceivable for endogenous NS1WNV
transiting through TNTs.
Another hypothesis might explain the possible advantage for the virus of the frequent occurrence of
NS1WNV-associated TNT-like nanofilaments, and even their proliferation, as previously observed [66]:
TNTs could facilitate the passage of WNV virions from one cell to another, so as to avoid their exposure
to the extracellular environment, a mechanism of cell-to-cell transmission that would be similar to
that of many other viruses [46–58]. Our observations that NS1WNV and the envelope glycoprotein
EWNV coexisted in the filamentous bridges between WNV-infected and non-infected cells supported
this hypothesis. Alternatively, TNTs could be used for the extracellular release of the WNV progeny,
a mechanism which has previously been envisaged. Analysis of WNV-infected Vero cells analyses by
transmission EM and atomic force microscopy suggested the exit of virus particles via the filopodia [66].
Regardless of the exact functions of the actin- and NS1WNV-containing TNT-like nanofilaments
observed in NS1WNV-expressing and WNV-infected cells, our data clearly showed that recombinant
NS1WNV protein alone, without any other WNV protein, was capable of modulating—either directly
or indirectly via host-cell intermediate factor(s)—the actin network of epithelial cells. These results
should be considered in future studies performed in the context of natural infections with WNV,
as they might provide further clues to elucidate the molecular mechanisms of the NS1-mediated
disruption of endothelial cell monolayers, and the subsequent vascular leakage, as observed with
sNS1DENV [17,24,75].
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